These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1153854)

  • 1. Evaluation of altered blood-brain barrier permeability to amino acids.
    Pollay M
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):763-6. PubMed ID: 1153854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movement of glycine across the blood-brain barrier of the rabbit.
    Pollay M
    J Neurobiol; 1976 Mar; 7(2):123-8. PubMed ID: 1262868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
    Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood-brain barrier and placental barrier for various amino acids in the mouse (whole body autoradiography studies)].
    Schultze B; Rabbani B; Maurer W
    Beitr Pathol; 1972; 147(4):352-65. PubMed ID: 4649096
    [No Abstract]   [Full Text] [Related]  

  • 5. Osmotic opening of tight junctions in cerebral endothelium.
    Brightman MW; Hori M; Rapoport SI; Reese TS; Westergaard E
    J Comp Neurol; 1973 Dec; 152(4):317-25. PubMed ID: 4784295
    [No Abstract]   [Full Text] [Related]  

  • 6. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
    Knudsen GM; Schmidt J; Almdal T; Paulson OB; Vilstrup H
    Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
    Pan GY; Liu XD; Liu GQ
    Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of autoregulatory response of the cerebral circulation after osmotic opening of the blood-brain barrier in dogs.
    Koźniewska E; Skolasińska K
    Acta Physiol Pol; 1980; 31(4):383-9. PubMed ID: 7446151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WR-2721 entry into the brain across a modified blood-brain barrier.
    Lamperti A; Conger AD; Jenkins O; Cohen G; Rizzo A; Davis ME; Sodicoff M
    Radiat Res; 1988 Aug; 115(2):303-13. PubMed ID: 2841714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 3',5'-AMP system in amino acid transport across the blood-brain barrier.
    Petkov V; Usunov P; Kushev V
    Acta Biol Med Ger; 1974; 33(4):371-83. PubMed ID: 4377374
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
    Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
    Anticancer Res; 1995; 15(6B):2593-6. PubMed ID: 8669830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of cerebral blood flow autoregulation after hypertonic urea administration.
    Koźniewska E; Skolasińska K
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):110-8. PubMed ID: 485676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of air bubbles on rabbit blood brain barrier.
    Hjelde A; Bolstad G; Brubakk AO
    Undersea Hyperb Med; 2002; 29(1):31-8. PubMed ID: 12507183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate.
    Ennis SR; Betz AL
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1095-102. PubMed ID: 3721787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
    Cornford EM; Young D; Paxton JW; Finlay GJ; Wilson WR; Pardridge WM
    Cancer Res; 1992 Jan; 52(1):138-43. PubMed ID: 1727374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion.
    Ellison MD; Povlishock JT; Merchant RE
    Cancer Res; 1987 Nov; 47(21):5765-70. PubMed ID: 3499219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.
    Chen CH; Toung TJ; Sapirstein A; Bhardwaj A
    J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood-brain barrier].
    Wakai S
    Nihon Rinsho; 1985 Feb; 43(2):244-8. PubMed ID: 2860260
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the corticotropin releasing hormone (CRH) on the brain-blood barrier permeability in cerebral ischemia in rats.
    Hendryk S; Jedrzejowska-Szypulka H; Jośko J; Jarzab B; Döhler KD
    J Physiol Pharmacol; 2002 Mar; 53(1):85-94. PubMed ID: 11939721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia.
    Sato T; Morishima Y; Shirasaki Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1042-7. PubMed ID: 12604680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.